Wiseguyreports.Com Adds “Human Growth Hormone (hGH) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database
Human Growth Hormone (hGH) is a peptide hormone produced by the pituitary gland that stimulates growth in children and adults. It plays an important role in the functioning of the human body by regulating body fluids, muscle and bone growth and fat metabolism of the body. The deficiency of growth hormone in the body is known as growth hormone deficiency which is administered by intramuscular or subcutaneous GH injections on a daily basis. Various therapeutics products are currently in the final phase of development and are expected to be launched in the coming years.
The market is expected to experience robust growth due to the increasing prevalence of GH and long-acting growth hormone formulations in development. Rising aging population accompanied by high growth of serious chronic diseases would keep the demand for hGH drugs high and would act as the growth catalyst for the global market.
The global long-acting growth hormone market is estimated to increase at a commendable rate in future, which is mainly due to increase in research and development activities and increasing occurrence of pituitary dysfunction. TransCon is expected to dominate the market due to ease of use and high efficacy. The market will see a shift in the use of long-acting hormone drugs from daily basis products, positively impacting the market.
Geographically, the U.S. dominated the market owing to its advance healthcare infrastructure. Majority of the players are based in the U.S., thus leading to the highest revenue from this region. The U.S. human growth hormone market is anticipated to grow at a steady rate owing to high research and development efforts.
The report “Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)” analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have been profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global market along with the study of the regional markets.
Table of Content
2. Global hGH Market
3. Regional Markets
3.1 The U.S.
3.1.1 The U.S. hGH Market Forecast by Value
3.1.2 The U.S. hGH Market by Indication
3.1.3 The U.S. Pediatric GH Market Forecast by Value
3.1.4 The U.S. Pediatric GH Market by Indication
3.1.5 The U.S. Pediatric GHD Market Forecast by Value
3.1.6 The U.S. Other Pediatric Indications Market Forecast by Value
3.1.7 The U.S. Adult GHD Market Forecast by Value
3.1.8 The U.S. Adult GHD Market Forecast by Value
3.1.9 The U.S. Pediatric GHD Patient Population Forecast
3.1.10 The U.S. Pediatric GHD Patient Population by Type
3.1.11 The U.S. TransCon Revenue Forecast
4. Global Human Growth Hormone Market Opportunity
5. Market Dynamics
5.1 Growth Drivers
5.2 Trends & Development
6. Competitive Landscape
7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Pfizer, Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Eli Lilly and Company
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Novo Nordisk A/S
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
List of Figures
hGH Secretion Control
hGH’s Physiological Effect
hGH Market Segmentation by Indication
Global hGH Market by Value (2014-2018)
Global hGH Market Forecast by Value (2019-2023)
Global hGH Market by Volume (2014-2018)
Global hGH Market Forecast by Volume (2019-2023)
Global hGH Market Share by Indication (2018)
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)